In my trial, we are injecting CRISPR directly into the bloodstream to correct a faulty gene in liver cells—it’s a profound step for rare metabolic diseases. But in India, the immense cost and need for specialised monitoring centres make it a distant dream for most families right now. I know this because my own patient list is filled with fathers, like I am, whose hope is real, but whose savings, like my pension, are measured in lakhs against crores. We are proving the science works, beta, but the real treatment must wait for its time to become affordable.
#exams#study
Jump in to reply — no account needed.